| Active and Passive Immunity against Borrelia burgdorferi Decorin Binding Protein A (DbpA) Protects against Infection MS Hanson, DR Cassatt, BP Guo, NK Patel, MP McCarthy, DW Dorward, ... Infection and immunity 66 (5), 2143-2153, 1998 | 198 | 1998 |
| DbpA, but Not OspA, Is Expressed by Borrelia burgdorferi during Spirochetemia and Is a Target for Protective Antibodies DR Cassatt, NK Patel, ND Ulbrandt, MS Hanson Infection and Immunity 66 (11), 5379-5387, 1998 | 131 | 1998 |
| A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. A Truneh, D Buck, DR Cassatt, R Juszczak, S Kassis, SE Ryu, D Healey, ... Journal of Biological Chemistry 266 (9), 5942-5948, 1991 | 101 | 1991 |
| Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy DR Cassatt, CA Fazenbaker, CM Bachy, MS Hanson Seminars in radiation oncology 12 (1), 97-102, 2002 | 97 | 2002 |
| Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen WI White, DR Cassatt, J Madsen, SJ Burke, RM Woods, NM Wassef, ... Vaccine 13 (12), 1111-1122, 1995 | 93 | 1995 |
| Medical countermeasures against nuclear threats: radionuclide decorporation agents DR Cassatt, JM Kaminski, RJ Hatchett, AL DiCarlo, JM Benjamin, ... Radiation research 170 (4), 540-548, 2008 | 90 | 2008 |
| Subcutaneous administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model DR Cassatt, CA Fazenbaker, G Kifle, CM Bachy International Journal of Radiation Oncology* Biology* Physics 57 (3), 794-802, 2003 | 56 | 2003 |
| The requirement for surface Ig signaling as a prerequisite for T cell: B cell interactions. A possible role for desialylation. KP Kearse, DR Cassatt, AM Kaplan, DA Cohen Journal of immunology (Baltimore, Md.: 1950) 140 (6), 1770-1778, 1988 | 46 | 1988 |
| Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program CI Rios, DR Cassatt, AL DiCarlo, F Macchiarini, N Ramakrishnan, ... Drug development research 75 (1), 23-28, 2014 | 43 | 2014 |
| Evidence for Vaccine Synergy between Borrelia burgdorferi Decorin Binding Protein A and Outer Surface Protein A in the Mouse Model of Lyme Borreliosis MS Hanson, NK Patel, DR Cassatt, ND Ulbrandt Infection and immunity 68 (11), 6457-6460, 2000 | 43 | 2000 |
| Commonalities between COVID-19 and radiation injury CI Rios, DR Cassatt, BA Hollingsworth, MM Satyamitra, YS Tadesse, ... Radiation research 195 (1), 1-24, 2021 | 40 | 2021 |
| Medical Countermeasures for Platelet Regeneration after Radiation Exposure: Report of a Workshop and Guided Discussion Sponsored by the National Institute of Allergy and … AL DiCarlo, M Poncz, DR Cassatt, JR Shah, CW Czarniecki, ... Radiation research 176 (1), e0001-e0015, 2011 | 34 | 2011 |
| Effects of dose and schedule on the efficacy of ethyol: preclinical studies DR Cassatt, CA Fazenbaker, G Kifle, CM Bachy Seminars in oncology 30, 31-39, 2003 | 33 | 2003 |
| Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine DR Cassatt, CA Fazenbaker, G Kifle, CM Bachy Seminars in oncology 29 (6), 2-8, 2002 | 31 | 2002 |
| Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure DR Cassatt, CA Fazenbaker, CM Bachy, G Kifle, MP McCarthy International Journal of Radiation Oncology* Biology* Physics 61 (3), 901-907, 2005 | 30 | 2005 |
| Acute radiation syndrome and the microbiome: impact and review BA Hollingsworth, DR Cassatt, AL DiCarlo, CI Rios, MM Satyamitra, ... Frontiers in Pharmacology 12, 643283, 2021 | 28 | 2021 |
| Challenges and benefits of repurposing products for use during a radiation public health emergency: lessons learned from biological threats and other disease treatments AL DiCarlo, DR Cassatt, WE Dowling, JL Esker, JA Hewitt, O Selivanova, ... Radiation research 190 (6), 659-676, 2018 | 28 | 2018 |
| Conformational Nature of the Borrelia burgdorferiDecorin Binding Protein A Epitopes That Elicit Protective Antibodies ND Ulbrandt, DR Cassatt, NK Patel, WC Roberts, CM Bachy, ... Infection and immunity 69 (8), 4799-4807, 2001 | 25 | 2001 |
| NIAID/NIH radiation/nuclear medical countermeasures product research and development program N Hafer, D Cassatt, A DiCarlo, N Ramakrishnan, J Kaminski, MK Norman, ... Health physics 98 (6), 903-905, 2010 | 24 | 2010 |
| Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses MP Reddy, EF Webb, D Cassatt, D Maley, JC Lee, DE Griswold, A Truneh International journal of immunopharmacology 16 (10), 795-804, 1994 | 22 | 1994 |
